From: Randomized double blind clinical trial on the effect of oral α-cyclodextrin on serum lipids
Inclusion criteria |
• Males and females, ages of 18–75. |
• Understands and provides written, informed consent. |
Exclusion Criteria |
• Pregnancy or breastfeeding. |
• BMI < 18.5 |
• Weight (change > 10 % over in the past 3 months). |
• Low-fat (<20 %) diet. |
• Less than 3 meals/snacks per day |
• Use of medications for at least six weeks: soluble fiber supplements, BAS, plant sterol supplements, long term antibiotics, anticoagulants, anticonvulsants, antiarrhythmics, cyclosporine, mycophenolate, synthroid, vitamin A, E and K or drugs taken with a meal. |
• Chronic diarrhea, gastric bypass or lapband procedures, ostomies, bowel motility problems, or conditions that could affect intestinal fat absorption. |
• New or multiple medications. |
• Type I or type II diabetes. |
• Use of α-CD in any of its commercial form. |
• Condition or disorder that may affect the outcome of the study or the safety of the volunteer. |